Edition:
India

Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

371.20INR
3:50pm IST
Change (% chg)

Rs15.90 (+4.48%)
Prev Close
Rs355.30
Open
Rs355.00
Day's High
Rs375.40
Day's Low
Rs355.00
Volume
1,816,372
Avg. Vol
2,229,801
52-wk High
Rs468.90
52-wk Low
Rs332.25

Chart for

About

Cadila Healthcare Limited is an India-based pharmaceutical company. The Company's subsidiaries include Zydus Wellness Limited, Windlas Healthcare Pvt Ltd, Liva Pharmaceuticals Limited, Biochem Pharmaceutical Industries Limited, Zydus Technologies Limited, German Remedies Limited, Dialforhealth India Limited, Dialforhealth Unity... (more)

Overall

Beta: 0.50
Market Cap(Mil.): Rs511,564.19
Shares Outstanding(Mil.): 1,023.74
Dividend: 3.20
Yield (%): 0.96

Financials

  CADI.NS Industry Sector
P/E (TTM): 41.67 30.86 33.64
EPS (TTM): 11.99 -- --
ROI: -- 14.72 14.22
ROE: -- 16.27 15.99

UPDATE 2-Kraft Heinz to sell part of India business for about $630 mln

* Deal does not assume any debt (Recasts throughout to add background, deal details)

24 Oct 2018

Zydus Wellness, Cadila to buy Kraft Heinz India

Oct 24 Indian consumer company Zydus Wellness Ltd and Cadila Healthcare Ltd will jointly buy Heinz India Private Ltd for 45.95 billion rupees ($627.18 million).

24 Oct 2018

Kraft Heinz to sell part of Indian businesses to drugmaker Zydus: Bloomberg

Kraft Heinz Co has agreed to sell a portfolio of its Indian businesses, including children's drink brand Complan, to Indian drugmaker Zydus Wellness Ltd, Bloomberg reported on Tuesday, citing sources.

23 Oct 2018

Kraft Heinz to sell part of Indian businesses to drugmaker Zydus - Bloomberg

Kraft Heinz Co has agreed to sell a portfolio of its Indian businesses, including children's drink brand Complan, to Indian drugmaker Zydus Wellness Ltd, Bloomberg reported on Tuesday, citing sources.

23 Oct 2018

UPDATE 1-Kraft Heinz to sell part of Indian businesses to drugmaker Zydus - Bloomberg

Oct 23 Kraft Heinz Co has agreed to sell a portfolio of its Indian businesses, including children's drink brand Complan, to Indian drugmaker Zydus Wellness Ltd, Bloomberg reported https://www.bloomberg.com/news/articles/2018-10-23/kraft-is-said-to-agree-to-sell-package-of-indian-assets-to-zydus on Tuesday, citing sources.

23 Oct 2018

Kraft Heinz to sell part of Indian businesses to drugmaker Zydus - Bloomberg

Oct 23 Kraft Heinz Co has agreed to sell a portfolio of its Indian businesses, including children's drink brand Complan, to Indian drugmaker Zydus Wellness Ltd, Bloomberg reported https://www.bloomberg.com/news/articles/2018-10-23/kraft-is-said-to-agree-to-sell-package-of-indian-assets-to-zydus on Tuesday, citing sources.

23 Oct 2018

BUZZ-Weak Q1 expected for Cadila, Lupin; improving trends for Cipla, Sun - Credit Suisse

** April-June quarter should be weak for Cadila Healthcare Ltd and Lupin Ltd with sharp declines in U.S. sales q-o-q - Credit Suisse (CS)

09 Jul 2018

Earnings vs. Estimates